Form 4 for AXGN Axogen, Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0000805928-22-000063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-03 | 2022-06-01 | AXGN | Gold Mark Stephen | Dir | M - OptEx | $0.00 | +3,036 | 305.5K | +1% | $0 |
| DM | 2022-06-03 | 2022-06-01 | AXGN | Gold Mark Stephen | Dir | A - Grant | $0.00 | +18.3K | 11.8K | New | $0 |
| D | 2022-06-03 | 2022-06-01 | AXGN | Gold Mark Stephen | Dir | M - OptEx | $0.00 | -3,036 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | M | A | 3,036 | $0.00 | 305,475 | D | — | — | (F1) This reflects the number of restricted stock units that vested on June 1, 2022. (F2) The shares of common stock for Dr. Gold include 31,900 shares held directly, 159,575 shares held jointly by Dr. Gold and his wife, indirect ownership of 22,000 shares held by Dr. Gold's spouse in revocable trusts, and indirect ownership of 92,000 shares held by MJSK, Ltd., a decedent investment trust. |
| 2 | Derivative | Restricted Stock Units | 2022-06-01 | A | A | 6,459 | $0.00 | 6,459 | D | — · — to — | 6,459 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F5) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2022-06-01 | M | D | 3,036 | $0.00 | 0 | D | — · — to — | 3,036 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F4) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. |
| 4 | Derivative | Stock Option (right to purchase) | 2022-06-01 | A | A | 11,811 | $0.00 | 11,811 | D | $9.29 · — to 2032-06-01 | 11,811 Common Stock | (F5) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units. |